A trial to learn if odronextamab is safe and well-tolerated and how well it works compared to rituximab combined with different types of chemotherapy for participants with follicular lymphoma

Category Primary study
Registry of TrialsClinical Trials Information System
Year 2023
This article has no abstract
Epistemonikos ID: 00b40fdbc4ae07c613170d5cf676203db3b9d181
First added on: Mar 21, 2025